Inhibitory PAS domain protein (IPAS) is a bifunctional protein that downregulates hypoxic gene expression and exerts proapoptotic activity by preventing prosurvival activity of Bcl-x L and its related factors. Proapoptotic activity of IPAS is attenuated by the activation of the PINK1-Parkin pathway, and involved in neuronal degeneration in an experimental mouse model of Parkinson's disease. The current study shows that phosphorylation of IPAS at Ser184 by MAPK-activated protein kinase 2 (MK2 or MAP-KAPK2) enhances the proapoptotic function of IPAS. Perinuclear clustering of mitochondria and activation of caspase-3 caused by the transient expression of EGFP-IPAS were increased by UVB irradiation. The C-terminal region of IPAS mediated the UVB susceptibility of IPAS. Increase in IPASinduced mitochondrial clustering by UVB was completly inhibited by the p38 MAPK inhibitor SB203580. Mass spectrometry analysis of UVB-activated IPAS identified several phosphorylation sites in the C-terminal region containing p38 MAPK consensus phosphorylation sites at Ser219 and Ser223, and an MK2 consensus site at Ser184. Although mutations of Ser219 and Ser223 to Ala did not suppress the UVB-induced mitochondrial clustering, replacement of Ser184 with Ala blocked it. A phosphomimetic substitution at Ser184 enhanced mitochondrial clustering and activation of caspase-3 without UVB exposure. Furthermore, binding affinity to Bcl-x L was increased by the mutation. Treatment of PC12 cells with CoCl 2 caused activation of MK2 and mitochondrial clustering. IPAS-dependent cell death induced by CoCl 2 in PC12 cells was decreased by the treatment with the MK2 inhibitor MK2 inhibitor III and by siRNA-directed silencing of MK2.
Introduction
Inhibitory PAS domain protein (IPAS) is a splicing variant of hypoxia-inducible factor (HIF)-3a, and suppresses transactivation activity of HIF-1, which is a master regulator of hypoxic gene expression, by directly binding to its oxygen-dependent subunit, HIF1a [1, 2] . IPAS exhibits a tissue-specific expression Abbreviations HIF, hypoxia-inducible factor; IPAS, inhibitory PAS domain protein; MK2, MAPK-activated protein kinase 2; MPTP, 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine; PD, Parkinson's disease; SNpc, substantia nigra pars compacta; UVB, ultraviolet B.
pattern [1] and is upregulated by hypoxia via activation of HIF-1 [3] . IPAS is also induced by oxidative stress and cytokines through activation of the classical NFjB pathway [4, 5] , and contributes to apoptotic cell death by reducing the capacity of prosurvival proteins such as Bcl-x L to interact with the prodeath factor Bax [6] . Recently, we have clarified that IPAS is intimately associated with neuronal cell death in Parkinson's disease (PD) [7] . PD can be classified into two forms, sporadic (90-95% of all cases) and familial (5-10%) forms. Familial forms of PD are further divided into two types according to differences in transmission patterns, autosomal-dominant and autosomal-recessive forms [8] . Mutations in PARK2 (Parkin) and PARK6 (PINK1) are responsible for autosomal-recessive PD forms. Recently, the two proteins were found to constitute a pathway that plays a central role in the quality control of mitochondria [9] [10] [11] . In damaged mitochondria, PINK1 protein kinase phosphorylates Parkin to activate its ubiquitin E3 ligase activity, resulting in proteasomal degradation of mitochondrial proteins, a process necessary for the initiation of mitophagy. We found that IPAS is a substrate of both PINK1 and Parkin, and phosphorylation of IPAS at Ser12 by PINK1 is a prerequisite for subsequent ubiquitination of IPAS by Parkin [7] . IPAS-induced apoptosis in CoCl 2 -treated PC12 cells was attenuated by PINK1 and Parkin activated by treatment with the protonophore carbonyl cyanide m-chlorophenyl hydrazone.
The dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is most widely used to produce animal models of PD [12] . Administered MPTP is metabolized to MPP + in glial cells, and taken up into neurons by the dopamine transporter. Oxidative stress produced by MPP + is considered to cause cell death of dopaminergic neurons in the substantia nigra pars compacta (SNpc), leading to the development of PD. Intraperitoneal injection of MPTP to mice strongly induced IPAS mRNA in neurons of the central nervous system including dopaminergic neurons in the SNpc [7] . MPTP-induced loss of dopaminergic neurons was reduced in IPAS-deficient mice, and expression of IPAS in neurons in the SNpc of patients with sporadic PD was significantly increased.
Oxidative stress often mediates activation of p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK). p38 MAPK and JNK are strongly activated by ultraviolet B (UVB) irradiation and known to have profound effects on cell proliferation, survival and death. Several reports have shown that activation of p38 MAPK and JNK is associated with the development of PD [13] [14] [15] . These studies led us to investigate the possibility that proapoptotic activity of IPAS may be regulated by the two stress-activated MAP kinases.
The current study clarified that mitochondrial clustering and apoptosis caused by IPAS was augmented by UVB irradiation. The p38 MAPK inhibitor SB203580 completely inhibited UVB-dependent activation of the IPAS-induced proapoptotic cascade. Determination of phosphorylated residues in UVB-activated IPAS by LC-MS/MS analysis and subsequent mutational analysis of the phosphorylation sites demonstrated that phosphorylation at Ser184 by MAP kinase-activated protein kinase 2 (MK2 or MAP-KAPK2), a direct substrate of p38 MAPK, is essential for the UVB-induced increase in proapoptotic activity of IPAS. In PC12 cells treated with CoCl 2 , activation of MK2 as well as induction of IPAS was found. Inhibition of MK2 activity by a specific MK2 inhibitor and by siRNAs directed against MK2 attenuated apoptosis caused by IPAS in PC12 cells.
Results

Increase in IPAS-dependent mitochondrial clustering by UVB irradiation
We described previously that transiently expressed EGFP-IPAS was capable to induce mitochondrial clustering [6] . As shown in Fig. 1A , the majority of the expressed EGFP-IPAS was found in the cluster of mitochondria localized in the perinuclear region. In order to investigate whether activation of p38 MAPK and/or JNK could enhance the clustering, HEK293T cells expressing EGFP-IPAS were exposed to UVB light which is known to activate both p38 MAPK and JNK signaling pathways. The number of cells that exhibited mitochondrial clustering was significantly increased in response to UVB exposure (Fig. 1B,C) . Treatment of cells with nocodazole before UVB irradiation completely blocked UVB-induced increase in mitochondrial clustering (Fig. 1D) , strongly suggesting that the clustering requires the microtubule network as reported by other groups [16] [17] [18] . When examined with two deletion mutants, IPAS N and IPAS C (Fig. 1B) , the C-terminal half of IPAS in which an intrinsic proapoptotic activity is localized contributed to the UVB-induced perinuclear clustering of mitochondria (Fig. 1B,C) .
Involvement of p38 MAPK pathway in UVBinduced mitochondrial clustering
In order to investigate the cause of increase in mitochondrial clustering by UVB irradiation, transfected cells were treated with the p38 MAPK inhibitor SB203580 or JNK inhibitor SP600125 just after UVB irradiation. Treatment with SB203580 completely suppressed UVB-induced increase in mitochondrial clustering. On the other hand, treatment with SP600125 partially inhibited the increment in clustering ( Fig. 2A) . Activation of the p38 MAPK pathway by UVB irradiation and its inhibition by the addition of SB203580 was confirmed by western blot analysis (Fig. 2B) . Time-dependent phosphorylation of MK2, a direct substrate of activated p38 MAPK, was completely inhibited by SB203580.
To identify residues phosphorylated by p38 MAPK, LC-MS/MS analysis of IPAS protein purified from UVB-irradiated HEK293T cells was performed. The analysis was also carried out using the 3FLAG-IPAS Q242R mutant which has an additional trypsin cleavage site to increase sequence coverage. This mutant was confirmed to induce mitochondrial clustering that was increased by UVB irradiation at levels similar to by UVB irradiation. HEK293T cells exposed to UVB were incubated in the presence of SB203580 or SP600125, and were lysed 1 or 2 h later. Cellular proteins were subjected to immunoblotting using antibodies to phosphorylated p38 MAPK (pp38), p38 MAPK, phosphorylated MK2 (pMK2), and MK2.
(C) Identification of phosphorylated Ser/Thr residues in UV-activated IPAS. HEK293T cells transfected with p3FLAG-IPAS WT or Q242R were exposed to UVB and lysed 90 min later. 3FLAG-IPAS and the IPAS Q242R mutant were affinity purified using an antibody against FLAG, resolved on SDS/PAGE gels, digested with trypsin and subjected to mass spectrometry analysis. Identified phosphorylation sites were indicated as circled P. HEK293T cells were transfected with a plasmid for EGFP-IPAS WT, S219,223A, T258A, or T265A mutant, and mitochondrial clustering was analyzed as described in Fig. 1B . n.s., not significant. *P < 0.05, **P < 0.01, ***P < 0.001.
that of the wild-type protein (data not shown). Peptide mapping from wild-type and mutated IPAS gave complete coverage of the C-terminal region except for the four C-terminal amino acids, and phosphorylation of Ser184, Thr187, Thr218, Ser219, and Ser223 localized in the C-terminal region was identified (Fig. 2C,D) . In addition to these residues, phosphorylation of Ser10, Thr12, Ser28, The40, Ser48, and Ser55 localized in the N-terminal region were found. As Ser219 and Ser223 followed by a Pro residue can be phosphorylated by p38 MAPK, we mutated the two Ser residues to Ala and examined the activity of the S219,223A mutant to enhance mitochondrial clustering in response to UVB. To our surprise, the mutant responded to UVB similar to the wild-type protein (Fig. 2E) . Mutants, IPAS T258A and T265A, with Ala replacement of possible phosphorylation sites by p38 MAPK also exhibited similar response to UVB irradiation (Fig. 2E) .
Involvement of MK2 in UVB-induced mitochondrial clustering and apoptotic cell death
Since direct phosphorylation by p38 MAPK was not involved in the activation of IPAS by UVB, we investigated whether MK2-mediated phosphorylation is responsible for the activation. Treatment with MK2 inhibitor III completely inhibited UVB-induced increase in mitochondrial clustering in both HEK293T and PC12 cells (Fig. 3A-C) . Involvement of MK2 in augmented mitochondrial clustering was confirmed by the experiment using siRNAs against MK2, and positive results were obtained (Fig. 3D) . UVB-induced increase in apoptotic cell death was analyzed in PC12 cells using an antibody against active caspase-3, an apoptotic marker (Fig. 4A) . apoptotic signal was significantly increased by UVB irradiation. Treatment with MK2 inhibitor III or siRNA-directed silencing of MK2 completely suppressed UVB-induced increase in apoptosis (Fig. 4B,  C) . Although we investigated UVB-dependent enhancement of apoptotic cell death using HEK293T cells, apoptosis with expression of active caspase-3 was not significantly increased (data not shown).
Effect of mutations at Ser184 on UVB-induced mitochondrial clustering and apoptotic cell death
The minimal consensus for MK2 phosphorylation is known to be RXXpS/T. Of five phosphorylated serine and threonine residues in the C-terminal region, only Ser184 satisfied the requirement. Thus, we replaced the Ser residue with the Ala or phosphomimetic Asp residue to show its importance, although the phosphorylation in the stimulated endogenous IPAS could not be confirmed directly. Although IPAS S184A caused mitochondrial clustering in HEK293T cells and apoptosis in PC12 cells comparable to the wild-type protein, UV stress-induced increase in clustering (Fig. 5A) and apoptosis (Fig. 5B) was completely lost by the substitution. In contrast, IPAS S184D caused increased mitochondrial clustering and apoptosis without UVB irradiation, and the enhanced level of clustering and apoptosis remained unchanged by UVB stimulation, arguing for direct phosphorylation of the Ser residue by MK2. In accordance with the results, affinity of IPAS to endogenous Bcl-x L was increased by the mutation to Asp (Fig. 5C ). On the other hand, the IPAS S184A mutant showed weak affinity to Bcl-x L comparable to wild-type protein. Inhibition of increase in apoptosis in response to UVB irradiation by an MK2 inhibitor. PC12 cells transfected with pEGFP-IPAS were pretreated with 20 lM MK2 inhibitor III for 2 h, exposed to UVB, and incubated for a further 4 h in the medium containing MK2 inhibitor III. Apoptotic cells were detected by immunofluorescent staining using an antibody against active caspase-3. Active caspase-3-positive cells with EGFP or EGFP-IPAS expression were indicated with arrows in (A). Scale bar, 20 lm. The number of active caspase-3-positive cells was counted in three independent experiments, and the ratio to EGFP-IPAS expressing cells is shown (B). (C) Inhibition of increase in IPAS-dependent apoptosis in response to UVB irradiation by the siRNA-mediated knockdown of MK2. PC12 cells were transfected with nontargeting (NT) siRNA or siRNA against MK2 24 h before transfection of pEGFP or pEGFP-IPAS. After incubation for 24 h, cells were exposed to UVB and apoptotic cells were analyzed 4 h later. n.s., not significant. *P < 0.05, **P < 0.01, ***P < 0.001. apoptosis [6] (Fig. 6A) . We investigated whether CoCl 2 treatment could induce activation of the p38 MAPK pathway in PC12 cells. As shown in Fig. 6A , treatment with CoCl 2 caused activation of the pathway in a concentration-dependent manner. CoCl 2 treatment also induced mitochondrial clustering in approximately 19% of cells, which was significantly suppressed by knockdown of IPAS (Fig. 6B,C) . Active caspase-3-positive cells were increased by the addition of CoCl 2 , and the induced level of apoptosis was partially but significantly suppressed by the treatment with an MK2 inhibitor (Fig. 6D,E) . The partial inhibition of apoptotic cell death was reproduced by the treatment with siRNAs against MK2 (Fig. 6F ). MK2-dependent apoptosis was further supported by decreased amount of cleaved PARP, which is digested by caspase-3 in apoptotic cells, by MK2 inhibition (Fig. 6G) and knockdown (Fig. 6H) .
Discussion
Perinuclear mitochondrial clustering that precedes cytochrome c release and caspase-3 activation is observed in a number of cell types in response to various external stresses [17, [19] [20] [21] . The temporal change was found in PC12 cells expressing EGFP-IPAS. However, the apoptotic process in HEK293T cells stopped at the stage of mitochondria clustering (data not shown), indicating that susceptibility of PC12 and HEK293T cells to apoptotic IPAS expression is significantly different. The current study demonstrated that mitochondrial clustering induced by expression of EGFP-IPAS was further enhanced by UVB irradiation. Analysis using inhibitors for p38 MAPK and JNK suggested that p38 MAPK was mainly responsible for mitochondrial clustering augmented by UVB exposure. Mutational analysis of phosphorylation sites in the C-terminal region of IPAS, however, strongly suggested that direct activation of IPAS by p38 MAPK was unlikely. Inhibition of MK2, an immediate downstream kinase of p38 MAPK, by treatment with a specific inhibitor or siRNAs against MK2 completely suppressed UVB-induced activation of IPAS. Determination of phosphorylation sites and subsequent mutational analysis suggested that Ser184 was the major phosphorylation site targeted by MK2. Taken together, these results suggested that phosphorylation at Ser184 by MK2, which is activated by UV-activated p38 HEK293T cells were transfected with a plasmid for EGFP-IPAS WT, S184A, or S184D, and exposed to UVB after incubation for 24 h. Mitochondrial clustering was analyzed as described in Fig. 1B. (B) Effect of mutations at Ser184 on UVB-induced apoptosis. PC12 cells were transfected, and exposed to UVB as described in (A). n.s., not significant. ***P < 0.001. (C) Binding affinity of EGFP-IPAS WT, S184A or S184D to endogenous Bcl-x L . HEK293T cells were transfected with a plasmid for EGFP-IPAS WT, S184A or S184D. After incubation for 48 h, cell lysates were prepared, and used for coimmunoprecipitation assay. Ratio of bound 3Myc-IPAS mutants to precipitated Bcl-x L is indicated. Cont., control; WT, wild-type.
MAPK, is a key determinant for activation of the proapoptotic activity of IPAS by UVB irradiation. Increased proapoptotic activity of IPAS by UVB irradiation may be due to an increase in affinity to Bclx L because IPAS with a phosphomimetic mutation at Ser184 showed increased binding to Bcl-x L . Presently MAPK-activated protein kinase 2 is involved in various cellular events such as inflammation, cell cycle, cell migration and apoptosis [22, 23] . In extraneural cells such as polymorphonuclear leukocyte [24] and cancer cells [25] , activation of MK2 through activation of p38 MAPK protects cells against injurious extracellular stimuli. In neural tissues, accumulating evidence implies that activation of the p38 MAPK pathway promotes neuronal apoptosis [26, 27] . Activation of MK2 is reported to be positively involved in the process of apoptosis [28, 29] . MK2 is abundantly expressed in the microglia, and plays a central role in neuroinflammation [30] . Upon lipopolysaccharide stimulation, large amounts of cytotoxic cytokines such as TNFa and IL-6 were produced from the microglia via activation of MK2, resulting in facilitation of neuronal apoptosis. In addition to the action of the cytotoxic cytokines, stressdependent increased production of nitric oxide was also postulated to mediate apoptosis. In primary neuronglia cocultures isolated from the midbrain of MK2-deficient mice, dopaminergic neurons were more resistant to the lipopolysaccharide stimulus than those from wild-type mice [29] . Furthermore, it was demonstrated that MK2-deficient mice were resistant to MPTPinduced neurodegeneration in the SNpc compared with wild-type mice, and that MK2 may act as an inducer of glial inflammation that causes detrimental effects on neurons [29] . In a transgenic mouse model of Alzheimer's disease, it was reported that activation of MK2 was associated with amyloid-b deposition, microglial activation and cytokine upregulation [30] . From these observations, it is concluded that neuronal apoptosis caused by activation of MK2 results from increased neuroinflammation. In contrast to the indirect role of MK2 in neurodegeneration, our findings strongly suggest that direct phosphorylation by MK2 of the proapoptotic protein IPAS, which is induced in nigral dopaminergic neurons of MPTP-treated mice [7] , contributes to MK2-induced neuronal cell death. Although expression levels of p38 MAPK in neurons are less than those in microglia, p38 MAPK and MK2 are expressed in the neurons including nigral dopaminergic neurons [30, 31] (S. Kasai & K. Sogawa, unpublished observation). Selective activation of p38 MAPK by MPTP treatment of mice was found in the dopaminergic neurons in the SNpc but not in the ventral tegmental area [31] .
To our knowledge, this is the first presentation that proapoptotic factors are phosphorylated by MK2 to regulate apoptosis. Our previous studies demonstrated that IPAS functions as a proapoptotic protein that mediates the reactive oxygen species-induced NF-jB signal to Bax [4, 5] . This study implies that IPAS also acts as a factor that links an apoptotic signal caused by activation of the p38 MAPK pathway to Bax. Based on this study, therapeutic strategy targeting MK2 may be beneficial for both familial and sporadic PD patients by ameliorating IPAS-mediated neurodegeneration as well as by reducing neuroinflammation through MK2-dependent activation of microglia.
Materials and methods
Reagents and antibodies
Nocodazole was obtained from Sigma-Aldrich (St. Louis, MO, USA). SB203580 and MK2 inhibitor III were obtained from Cayman Chemical (Ann Arbor, MI, USA). SP600125 and CoCl 2 were from Wako Pure Chemical Industries (Osaka, Japan). MitoRed was from Dojindo (Kumamoto, Japan). Antibodies against p38 MAPK (9212), phospho-p38 MAPK (9211), MK2 (12155), phospho-MK2 (3007), Bcl-x L (2764), and PARP (9542) were obtained from Cell Signaling Technology (Danvers, MA, USA). Antibodies against Tom20 (sc-11415) and Lamin B (sc-6217) were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Antibodies against GAPDH and active caspase-3 were purchased from Trevigen (Gaithersburg, MD, USA) and Promega (Madison, WI, USA), respectively. ON-TARGET plus rat MK2 siRNA and nontargeting siRNA were obtained from GE Dharmacon (Lafayette, CO, USA).
Plasmid construction
Mouse IPAS cDNA was kindly provided by Y. Makino. pEGFP-IPAS and its deletion mutants, pBOS-3Myc-IPAS and pBOS-3FLAG-IPAS were constructed as described previously [6, 7] . Point mutations in IPAS were introduced by PCR as described [32] 
Cell culture and transfection
The HEK293T and PC12 cells were obtained from the Cell Resource Center for Biomedical Research, Tohoku University, Sendai, Japan, and maintained as described previously [6] . HEK293T and PC12 cells were transfected with plasmid DNA using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instruction. Culture media were replaced 4 h after transfection and cells were incubated for the indicated times. For mass spectrometry analysis, HEK293T cells were transfected with plasmid DNA using polyethyleneimine as described [33] . siRNA-directed silencing of IPAS in PC12 cells were carried out as described [6] . For MK2 knockdown in PC12 cells, culture media were replaced with serum-free Dulbecco's modified Eagle's medium (DMEM), and cells were transfected with 20 nM siRNA using Lipofectamine RNAiMAX (Invitrogen). Culture media were replaced with 10% FBS in RPMI-1640 4 h after transfection, and cells were incubated for a further 72 h.
UVB irradiation
After replacing the medium with PBS, cells were exposed to 40 mJÁcm À2 of UVB light in a Spectrolinker XL-1500 (Spectronics, Westbury, NY, USA) equipped with 6 9 15 W UV-lamp (312 nm). After irradiation, PBS was aspirated and replaced with the culture medium. Cells were incubated for 2 h for mitochondrial staining or 4 h for active caspase-3 staining. Nocodazole was added to cell culture media 0.5 h prior to UVB irradiation at the concentration of 3 lM. SB203580 (20 lM) and SP600125 (20 lM) were added after UVB irradiation, and MK2 inhibitor III (20 lM) was added 2 h prior to UVB irradiation or CoCl 2 treatment.
Mass spectrometry analysis
HEK293T cells transfected with pBOS-3FLAG-IPAS were incubated for 24 h. Cells were exposed to UVB and harvested 90 min later. Cellular proteins were extracted in lysis buffer (20 mM HEPES, pH 7.5, 100 mM NaCl, 1.5 mM MgCl 2 , 1 mM EGTA, 10 mM Na 2 P 2 O 7 , 10% glycerol, 1% Triton X-100, 1 mM dithiothreitol, 1 mM Na 2 VO 4 , 1 mM PMSF, and 0.17 mgÁmL À1 aprotinin), and insoluble cell debris was removed by centrifugation at 20 000 g at 4°C for 10 min. The soluble fraction was mixed with Dynabeads protein-G (Thermo Fisher Scientific, Waltham, MA, USA) conjugated with anti-FLAG M2 mouse antibody (SigmaAldrich) and rotated at 4°C for 3 h. Proteins bound to the beads were washed with 0.1% Tween 20/PBS supplemented with 1 mM dithiothreitol, 1 mM Na 2 VO 4 , 1 mM PMSF, and 0.17 mgÁmL À1 aprotinin, eluted by boiling in 29 Laemmli sample buffer at 95°C for 3 min, separated by SDS/PAGE and stained with Coomassie Brilliant Blue R-250. A protein band of IPAS at around 39 kDa was excised from gels and subjected to in-gel reduction with 10 mM DTT in 25 mM ammonium bicarbonate. The reduced protein was alkylated with 55 mM iodoacetamide and digested with trypsin (Sigma-Aldrich). The resultant tryptic peptides were analyzed using a nano-flow HPLC-ESI-MS/MS system (Thermo Fisher Scientific) as described previously [34] . Peptide mapping was carried out using the MASCOT search engine (Matrix Science) against a mouse protein database and a custom database including IPAS Q242R. 
Immunofluorescent staining
Immunoprecipitation and Immunoblotting
Immunoprecipitation was carried out essentially as described [6] . Lysates from HEK293T cells expressing 3Myc-IPAS WT, S184A, or S184D were prepared 48 h after the transfection, and protein concentration was determined by the Bio-Rad protein assay (Hercules, CA, USA). Protein G Sepharose (GE Healthcare, Madison, WI, USA) and anti-Bcl-x L antibody were added to the lysates, and incubated at 4°C for 2 h. Incubated Protein G Sepharose was washed three times with PBS supplemented with 1 mM dithiothreitol, 1 mM Na 2 VO 4 , 1 mM PMSF and 0.17 mgÁmL À1 aprotinin. The immunoadsorbed proteins were eluted by boiling at 100°C for 3 min in 29 Laemmli sample buffer. Whole cell lysates extracted as described previously [6] were subjected to immunoblotting to detect p38 MAPK and MK2. For detection of PARP and Lamin B, cells were lysed directly in Laemmli sample buffer, and sonicated (UD-201; Tomy Seiko, Tokyo, Japan). Insoluble fraction was removed by centrifuge at 20 000 g for 10 min. Protein samples were resolved on SDS/PAGE gels and transferred to poly(vinylidene difluoride) membranes (Merck Millipore, Billerica, MA, USA). After blocking with 10% nonfat dried milk in 0.1% Tween 20/PBS, membranes were incubated with primary antibody diluted in Can Get Signal solution 1 (Toyobo, Osaka, Japan) at 4°C overnight, washed in 0.1% Tween 20/PBS and probed with horseradish peroxidase-conjugated secondary antibody (Jackson ImmunoResearch, West Grove, PA, USA) diluted in 5% nonfat dried milk in 0.1% Tween 20/PBS. The signal was detected using the ECLprime detection system (GE Healthcare).
RT-PCR
PC12 cells were treated with 100 or 150 lM CoCl 2 for 10 h, and total RNA was extracted from cells using Isogen (Nippon gene, Tokyo, Japan). RT-PCR was performed as described [7] .
Statistical analysis
Data are expressed as mean AE standard deviation of three independent experiments. Two-group experiments were analyzed by Student's t-test. Multiple comparisons were analyzed by two-way ANOVA followed by post hoc Tukey-Kramer test.
